Défi respire - 150 000 X MERCI conta.cc/4hrouyB
Les inscriptions pour la course sont terminées, mais il est toujours possible de faire un petit don @DefiRespire
Team Cath (Catherine Laplante)🏃🏃♂️🏃♀️ zeffy.com/fr-CA/team/team-ca…
Super entrevue ce matin à QUB radio
On parle d’environnement ♻️ et de restauration rapide 🍟🍔
@MathieuTraversy
@QubRadio
@LP_LaPresse
@kick1972
@TerrebonneVille qub.ca/balado/isabelle-perro…
Catherine Laplante retweeted
✨Share to spread the word
✨Lung cancer is affecting young people
✨The face of lung cancer is changing, and our awareness must too.
#cancer #cancerawareness #lungcancer #cancerfighter #patient #lcsm #earlyonset
August 1st was world lung cancer day
Here’s my story
instagram.com/reel/DM1bbD-M0…
Très fière de mon chum et toute l’équipe de Ti-Will
Terrebonne, pionnière au Québec
Restauration rapide | Finie la vaisselle jetable en France lp.ca/2zWfuQ via @lp_lapresse
@MathieuTraversy
Catherine Laplante retweeted
Today is World Lung Cancer Day
We stand with those facing it.
We remember those we’ve lost.
We speak up for those who don’t have the words yet.
Lung cancer is the leading cause of cancer death worldwide
Research matters.
And every single life impacted by this disease matters
💔💔💔
This video is about what cancer takes that can’t be seen on scans..
-identity
-safety
-certainty
-the version of yourself you didn’t know you’d lose
Thank you, @SamanthaM75074 for trusting me to help craft something so vulnerable. Your honesty helps others feel seen ❤️
#cancer
Frontiers | Young lung cancer: from diagnosis to survivorship @YoungLungCancer frontiersin.org/journals/onc…
FDA Approves Datroway for EGFR-Mutated Advanced Lung Cancer
Pourquoi santé Canada refuse de l’approuver? 🤷🏻♀️🇨🇦 curetoday.com/view/fda-appro…
Catherine Laplante retweeted
Impacts of co-mutations in oligometastatic and oligoprogressive non-small cell lung cancer with EGFR/ALK mutations—a narrative review of the current literature
tlcr.amegroups.org/article/v…
@OncogeneCancer @ALKPositiveinc @EgfrUk
Catherine Laplante retweeted
Prof @_ShankarSiva has received a $1.5M MRFF grant to lead PRIME-Lung — a trial testing if radiotherapy to the primary tumour can boost outcomes in advanced lung cancer (NSCLC).
🔗 Read more: petermac.org/about-us/news-a…
Adding Dato-DXd After Progression on Osimertinib Improves PFS in EGFR-Mutated NSCLC Trial oncologynewscentral.com/nscl…
“Quite Extraordinary Results” for Novel TKI in HER2-Mutated NSCLC Trial oncologynewscentral.com/nscl…
Catherine Laplante retweeted
Lung cancer isn’t just a diagnosis — it’s a journey of resilience, courage, and hope. In our latest collection of stories, you’ll meet incredible individuals who refuse to let lung cancer define them. Read their stories and be inspired: lungcancercanada.ca/find-sup…
Catherine Laplante retweeted
Can lung cancer patients live with metastatic disease?
Yes, they can!
78 yo pt EGFR-mutated oligo-progressive NSCLC received SABR radiotherapy to 22 locations over 11 years while on EGFR-targeted TX.
Outstanding quality of life minimal side effects, NED each time after SABR.













